These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35067759)

  • 1. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.
    Sun JJ; Perera B; Henley W; Angus-Leppan H; Sawhney I; Watkins L; Purandare KN; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Ashby S; De Silva R; Miller J; Philpott DE; Ashwin C; Howkins J; Slater H; Medhurst D; Shankar R
    J Neurol; 2022 May; 269(5):2750-2760. PubMed ID: 35067759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling increased risks in older adults with intellectual disability and epilepsy: Data from a national multicentre cohort study.
    Watkins LV; Henley W; Sun JJ; Perera B; Angus-Leppan H; Sawhney I; Purandare K; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Shankar R
    Seizure; 2022 Oct; 101():15-21. PubMed ID: 35850018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case-control study.
    Sun JJ; Watkins L; Henley W; Laugharne R; Angus-Leppan H; Sawhney I; Shahidi MM; Purandare K; Eyeoyibo M; Scheepers M; Lines G; Winterhalder R; Perera B; Hyams B; Ashby S; Shankar R
    J Neurol; 2023 Jul; 270(7):3527-3536. PubMed ID: 37022478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure and Sudden Unexpected Death in Epilepsy (SUDEP) characteristics in an urban UK intellectual disability service.
    Sun JJ; Perera B; Henley W; Ashby S; Shankar R
    Seizure; 2020 Aug; 80():18-23. PubMed ID: 32485614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability.
    Espadas C; Ballester P; Londoño AC; Almenara S; Aguilar V; Belda C; Pérez E; Peiró AM
    Psychiatry Res; 2020 Oct; 292():113321. PubMed ID: 32738553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between clinical presentation and the nature of care in adults with intellectual disability and epilepsy - national comparative cohort study.
    Badger S; Watkins LV; Bassett P; Roy A; Eyeoyibo M; Sawhney I; Purandare K; Wood L; Pugh A; Hammett J; Sheehan R; Tromans S; Shankar R
    BJPsych Open; 2024 Apr; 10(3):e94. PubMed ID: 38686441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality from sudden unexpected death in epilepsy (SUDEP) in a cohort of adults with intellectual disability.
    Kiani R; Tyrer F; Jesu A; Bhaumik S; Gangavati S; Walker G; Kazmi S; Barrett M
    J Intellect Disabil Res; 2014 Jun; 58(6):508-20. PubMed ID: 23647577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis.
    Branford D; Sun JJ; Burrows L; Shankar R
    Br J Clin Pharmacol; 2023 Jul; 89(7):2028-2038. PubMed ID: 37060156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit.
    Perera B; Chen J; Korb L; Borakati A; Courtenay K; Henley W; Tromans S; Shankar R
    Expert Opin Pharmacother; 2021 Jun; 22(8):1071-1078. PubMed ID: 33487043
    [No Abstract]   [Full Text] [Related]  

  • 10. Seizure-related complication rate in a residential population with epilepsy and intellectual disability (ECOMRAID-trial).
    Monté CPJA; Arends JBAM; Lazeron RHC; Tan IY; Boon PAJM
    Epilepsy Behav; 2023 Mar; 140():108995. PubMed ID: 36822042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review.
    Moon S; Watkins L; O'Dwyer M; Shankar R
    Expert Rev Neurother; 2024 Nov; 24(11):1097-1105. PubMed ID: 39160772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of people with intellectual disability admitted to hospital with constipation: identifying possible specific high-risk factors.
    Laugharne R; Wilcock M; Rees J; Wainwright D; Newton N; Sterritt J; Badger S; Bishop R; Bassett P; Shankar R
    J Intellect Disabil Res; 2024 Mar; 68(3):277-284. PubMed ID: 38031737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: A naturalistic case control study.
    Allard J; Sellers A; Henley W; McLean B; Parrett M; Rajakulendran S; Watkins L; Maguire M; Ellawela S; Tittensor P; Bransgrove J; Sen A; Mohanraj R; Bagary M; Ram S; Vernon N; Baldwin S; Gill J; Shankar R
    Seizure; 2024 Aug; 120():25-32. PubMed ID: 38897161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European perspective of perampanel response in people with Intellectual Disability.
    Allard J; Henley W; Snoeijen-Schouwenaars F; van Ool J; Tan I; Jurgen Schelhaas H; Majoie MHJM; Hudson S; McLean B; Shankar R
    Acta Neurol Scand; 2020 Sep; 142(3):255-259. PubMed ID: 32383205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity and Polypharmacy Are Independently Associated With Mortality in Older People With Intellectual Disabilities: A 5-Year Follow-Up From the HA-ID Study.
    Schoufour JD; Oppewal A; van der Maarl HJK; Hermans H; Evenhuis HM; Hilgenkamp TIM; Festen DA
    Am J Intellect Dev Disabil; 2018 Jan; 123(1):72-82. PubMed ID: 29281324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk?
    Young C; Shankar R; Palmer J; Craig J; Hargreaves C; McLean B; Cox D; Hillier R
    Seizure; 2015 Feb; 25():112-6. PubMed ID: 25457453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perampanel in the general population and in people with intellectual disability: Differing responses.
    Shankar R; Henley W; Wehner T; Wiggans C; McLean B; Pace A; Mohan M; Sadler M; Doran Z; Hudson S; Allard J; Sander JW
    Seizure; 2017 Jul; 49():30-35. PubMed ID: 28552718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Intellectual Disability With All-Cause and Cause-Specific Mortality in Sweden.
    Hirvikoski T; Boman M; Tideman M; Lichtenstein P; Butwicka A
    JAMA Netw Open; 2021 Jun; 4(6):e2113014. PubMed ID: 34156453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.